1950, The company predecessor for Xinan Pharmaceutical Factory Laboratory was founded

　　1951, Vinyl chloride used for Anti-hookworm was successfully developed

　　1964, Chongqing Pharmaceutical Research was founded

　　1978, moved to company’s present location on Tushan Road

　　1987, Ranitidine was successfully developed

　　1989, Clindamycin was successfully developed, and then was successfully manufactured in our pilot workshop which afterwards was approved by FDA in 1994.

　　1992, Fluconazole was successfully developed

　　1994, Milrinone was successfully developed.

　　1997, First FDA approval on Clindamycin API in China was authorized to CPRI

　　2000, Chongqing Carelife Pharma, a joint venture of CPRI was founded

　　2002, Acquired by Shanghai FosunPharma Group

　　2009, CRPI invested a start-up pharma-tech company Chongqing Fochon Pharma to get hands on new drug development

　　2009, Hold wholly and control over Chongqing Kangle Pharma

　　2010, Sucrose iron, Pemetrexed disodium API were approved by FDA

　　2012, Construction of Changshou API manufacturing facility started

　　2015, Construction of Changshou API manufacturing facility completed and put into use.